Clinical Trial Update: The Oxylipin Response as a New PrEdictive Biomarker of Patient Responsiveness to Biotherapy in Rheumatoid Arthritis (OPERA) [NA]

View source ↗

Summary

This clinical trial update discusses the OPERA study evaluating whether oxylipin response can predict which rheumatoid arthritis patients will respond to biothe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Rheumatoid Arthritis | NA | Status: COMPLETED